drugset / Trial / NCT00974675
A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
The study includes participants with moderate asthma who were randomly assigned to receive the study medication (CAT-354) or placebo.
Timeline
- Start
- 2006-09-29
- Primary completion
- 2007-08-03
- Completion
- 2007-08-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tralokinumab | Monoclonal antibody | 1 mg/kg | Intravenous |
| Subject | Tralokinumab | Monoclonal antibody | 5 mg/kg | Intravenous |
| Subject | Tralokinumab | Monoclonal antibody | 10 mg/kg | Intravenous |
Indications
No indication recorded.